一项关于在同时进行胰腺脏移植后预防血栓形成的研究
Jin-Peng Tu1, Xiao-Feng Shi1, Hui Wang1
1Organ Transplant Department, Tianjin First Central Hospital, Tianjin, China.
概括
在同时进行胰腺移植 (SPK) 后使用低分子量肝素并没有显著改变血栓形成率,但增加了胃肠道出血的风险. 仔细评估患者对于选择适当的血栓形成预防至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植手术 移植手术
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病是慢性功能衰竭的主要原因.
- 同时胰腺移植 (SPK) 是糖尿病患者末期病的首选治疗方法.
- SPK改善了患者的生活质量,并减少了与糖尿病相关的并发症.
研究的目的:
- 分析SPK后不同血栓形成预防策略相关的并发症的发生率和安全性.
- 为了比较接受低分子量肝素 (LMWH) 和未接受治疗的患者之间的结果.
主要方法:
- 从2019年1月到2022年12月,对58名SPK受益人的回顾性分析.
- 患者被分为两组:肝素 (接受LMWH) 和非肝素.
- 记录并比较了包括胰腺血栓和胃肠道出血在内的并发症.
主要成果:
- 肝素 (5.6%) 和非肝素 (4.6%) 组之间的胰腺血栓发生率没有统计学上显著的差异 (P>0.05).
- 与非肝素组 (13.6%) 相比,肝素组 (38.9%) 的胃肠道出血发生率明显高 (P<0.05).
结论:
- 手术后的LMWH抗凝剂可能会增加SPK患者胃肠道出血的风险.
- 术前对凝血状况和病史的评估对于风险分层至关重要.
- 建议个性化选择血栓形成预防药物,如LMWH或阿司匹林.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Acute Pancreatitis II: Clinical Manifestations and Management
118
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118


